Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fat modification in the diabetes diet.

U Julius1

  • 1Institute and Policlinics of Clinical Metabolic Research, University Clinics Dresden, Dresden, Germany. julius@rcs.urz.tu-dresden.de

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|May 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The German Lipoprotein Apheresis Registry-Summary of the eleventh annual report.

Atherosclerosis·2024
Same author

Correction: Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2022
Same author

Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic Apheresis.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2022
Same author

Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels.

Clinical research in cardiology supplements·2019
Same author

Lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 inhibitors.

Clinical research in cardiology supplements·2019
Same author

Lipoprotein(a)-an interdisciplinary challenge.

Clinical research in cardiology supplements·2019

Monounsaturated fatty acids (MUFA) in diabetic diets may lower glucose and blood pressure. Fish oil effectively reduces triglycerides, while polyunsaturated fatty acids (PUFA) show mixed results in diabetic patients.

Area of Science:

  • Cardiovascular Nutrition
  • Diabetes Mellitus Management
  • Dietary Fat Metabolism

Background:

  • Dietary fat modification is crucial for managing diabetes complications.
  • Understanding the impact of different fatty acids on metabolic health in diabetics is essential.

Purpose of the Study:

  • To review the effects of monounsaturated fatty acids (MUFA) and polyunsaturated fatty acids (PUFA) on diabetic patients.
  • To evaluate the impact of specific fatty acids like alpha-linolenic acid and fish oil on cardiovascular risk and metabolic parameters in diabetes.

Main Methods:

  • Literature review of studies comparing carbohydrate-rich diets with MUFA-rich diets in diabetic patients.
  • Analysis of studies comparing MUFA-rich diets with PUFA-rich diets.
  • Inclusion of data from landmark studies like the Lyon Diet Heart Study and Nurses' Health Study.

Related Experiment Videos

Main Results:

  • MUFA-rich diets were associated with lower glucose concentrations and blood pressure compared to carbohydrate-rich diets.
  • PUFA-rich diets showed variable effects on lipids and glucose, with some studies reporting higher levels of LDL-cholesterol and fasting glucose.
  • Fish oil demonstrated a significant triglyceride-lowering effect, with mixed results on glucose control but potential benefits for nerve function.

Conclusions:

  • MUFA-rich diets appear beneficial for glucose control and blood pressure in diabetic individuals.
  • A balanced intake of omega-3 and omega-6 polyunsaturated fatty acids (PUFA) is recommended, with a suggested n-6/n-3 ratio not exceeding 4-6.
  • Fish oil is effective for triglyceride reduction and may improve nerve function in diabetic patients.